- Home
- Results news
- Shreyas Intermediates
- Q2 FY27 results
Shreyas Intermediates Q2 FY27 results: net loss narrows to ₹0.10 crore
Shreyas Intermediates Ltd reported standalone Q2 FY27 revenue of ₹0 crore and a net loss of ₹0.10 crore. Total income was ₹0.12 crore, while basic EPS was ₹0.01; total expenses declined to ₹0.22 crore from ₹10.73 crore in Q2 FY26.
Key points
- Standalone revenue was ₹0 crore in Q2 FY27, against ₹10.37 crore in Q2 FY26.
- The company reported a net loss of ₹0.10 crore, compared with a net loss of ₹0.24 crore a year earlier.
- EBITDA was a loss of ₹0.01 crore, compared with EBITDA of ₹0.07 crore in Q2 FY26.
- Total income was ₹0.12 crore, down 98.9% from ₹10.49 crore in Q2 FY26.
- Basic EPS was ₹0.01, compared with ₹0.03 in Q2 FY26.
How did Shreyas Intermediates perform in Q2 FY27?
Shreyas Intermediates reported standalone revenue of ₹0 crore for Q2 FY27, compared with ₹10.37 crore in Q2 FY26. Other income was ₹0.12 crore, taking total income to ₹0.12 crore against ₹10.49 crore in the year-ago quarter. The company reported a net loss of ₹0.10 crore and basic EPS of ₹0.01, compared with a net loss of ₹0.24 crore and basic EPS of ₹0.03.
Against Q1 FY27, revenue and total income were unchanged at ₹0 crore and ₹0.12 crore, respectively. Total expenses fell to ₹0.22 crore from ₹0.28 crore, while EBITDA improved to a loss of ₹0.01 crore from a loss of ₹0.07 crore. The net loss narrowed to ₹0.10 crore from ₹0.16 crore, and basic EPS was ₹0.01 against ₹0.02. EBITDA margin was not reported.
| ₹ crore | Q2 FY27 | Q1 FY27 | Q2 FY26 | YoY | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 0 | 0 | 10.37 | ||
| Other income | 0.12 | 0.12 | 0.12 | +0.0% | +0.0% |
| Total expenses | 0.22 | 0.28 | 10.73 | −97.9% | −21.4% |
| EBITDA | −0.01 | −0.07 | 0.07 | turned to loss | |
| Profit before tax | −0.10 | −0.16 | −0.24 | ||
| Tax | 0 | 0 | 0 | ||
| Net profit | −0.10 | −0.16 | −0.24 | ||
| EPS (₹) | −0.01 | −0.02 | −0.03 |
EBITDA here is revenue from operations less operating costs (total expenses excluding finance costs and depreciation): before other income and exceptional items. Growth is shown only when both figures are positive. Source: Company's results filing (XBRL).
What changed in Shreyas Intermediates' costs and profit?
Total expenses fell by ₹10.51 crore to ₹0.22 crore in Q2 FY26, with cost of materials down ₹9.71 crore, depreciation and amortisation down ₹0.22 crore and other expenses down ₹0.02 crore. Employee cost increased by ₹0.01 crore, while finance costs, other income and tax were unchanged. There was no exceptional item in either quarter, and the company reported a net loss of ₹0.10 crore.
| ₹ crore | Q2 FY27 | Q2 FY26 | Change | Change % |
|---|---|---|---|---|
| Cost of materials | 0 | 9.71 | −9.71 | |
| Employee cost | 0.01 | 0 | +0.01 | |
| Finance costs | 0 | 0 | 0 | |
| Depreciation | 0.21 | 0.43 | −0.22 | −51.2% |
| Other expenses | 0 | 0.02 | −0.02 | |
| Total expenses | 0.22 | 10.73 | −10.51 | −97.9% |
| Other income | 0.12 | 0.12 | 0 | +0.0% |
| Tax | 0 | 0 | 0 |
Source: Company's results filing (XBRL).
How did the first half of FY27 go?
| ₹ crore | H1 FY27 | H1 FY26 | Change |
|---|---|---|---|
| Revenue from operations | 0 | 16.69 | |
| Profit before tax | −0.26 | −0.58 | |
| Net profit | −0.26 | −0.58 | |
| EPS (₹) | −0.04 | −0.08 |
Source: Company's results filing (XBRL).
What do the balance sheet and cash flow show?
As on 30 September 2026, total assets were ₹24.69 crore, compared with ₹24.95 crore on 31 March 2026, while total equity was ₹14.86 crore against ₹15.12 crore. Borrowings remained ₹7.74 crore and cash and cash equivalents remained ₹0.06 crore. Inventories were ₹0.03 crore, trade receivables ₹2.56 crore and trade payables ₹2.04 crore. For H1 FY27, net cash generated from operating activities was ₹0.24 crore, net cash used in investing activities was ₹0.24 crore and financing cash flow was unchanged at ₹0 crore; the corresponding H1 FY26 figures were also ₹0.24 crore, ₹0.24 crore and ₹0 crore.
| ₹ crore | As of 30 September 2026 | As of 31 March 2026 |
|---|---|---|
| Total assets | 24.69 | 24.95 |
| Total equity | 14.86 | 15.12 |
| Borrowings | 7.74 | 7.74 |
| Cash and equivalents | 0.06 | 0.06 |
| Inventories | 0.03 | 0.03 |
| Trade receivables | 2.56 | 2.56 |
Source: Company's results filing (XBRL).
| ₹ crore | H1 FY27 | H1 FY26 |
|---|---|---|
| Cash from operations | 0.24 | 0.24 |
| Cash from investing | −0.24 | −0.24 |
| Cash from financing | 0 | 0 |
| Capital expenditure | 0 | 0 |
Source: Company's results filing (XBRL).
How has Shreyas Intermediates done over the last 8 quarters?
Revenue peaked at ₹10.37 crore in Q2 FY26 and was ₹0 crore in Q2 FY27. The net loss improved from ₹0.24 crore in Q2 FY26 to ₹0.16 crore in Q1 FY27 and ₹0.10 crore in Q2 FY27. EBITDA margin was 0.7% in Q2 FY26, while margin was not reported for the latest quarters, so the reported margin trend cannot be assessed.
How did Shreyas Intermediates shares react?
The results were announced after market hours on 23 October 2026. The stock fell 1.9% on the reaction day, by 12.2% by the next day's close and by 5.0% by the fifth session, measured from the pre-results close of ₹7.40. The Commodity Chemicals industry median was unchanged on the reaction day, rose 1.7% by the next day's close and rose 1.4% by five sessions; the stock underperformed the industry by 1.9 percentage points, 13.9 percentage points and 6.4 percentage points, respectively. Earlier reaction-day moves included falls of 4.9% on 28 May 2026, 5.0% on 13 February 2026 and 5.3% on 28 May 2025.
| After the filing | Stock | Commodity Chemicals median |
|---|---|---|
| Reaction day | −1.9% | +0.0% |
| Next day | −12.2% | +1.7% |
| 5 days | −5.0% | +1.4% |
Minutes are measured from the price when the filing appeared; days from the previous close. Source: MarketPing price-reaction measurement.
| Results filed on | Stock on the reaction day |
|---|---|
| 28 May 2026 | −4.9% |
| 13 February 2026 | −5.0% |
| 14 November 2025 | +3.4% |
| 8 August 2025 | +1.0% |
| 28 May 2025 | −5.3% |
| 14 August 2024 | −6.2% |
| 27 May 2024 | −1.1% |
Source: MarketPing price-reaction measurement.
How did other Commodity Chemicals companies do?
Sixteen other Commodity Chemicals companies filed for the quarter, with a median revenue growth of 18.2%. Thirteen of the 18 peers whose profit was compared reported higher profit. The data also records the number of peers growing slower and faster than Shreyas Intermediates, but does not provide those two counts.
| Shreyas Intermediates revenue growth (YoY) | not comparable |
|---|---|
| Median of 16 other Commodity Chemicals companies | +18.2% |
| Companies whose net profit rose | 13 of 18 |
Source: Filed results (XBRL) of the industry's companies.
Quick answers
What was Shreyas Intermediates' revenue in Q2 FY27?
Revenue from operations was ₹0 crore, against ₹10.37 crore in Q2 FY26 (standalone).
Did Shreyas Intermediates make a profit in Q2 FY27?
No. It reported a net loss of ₹0.10 crore, against a net loss of ₹0.24 crore in Q2 FY26.
What was Shreyas Intermediates' EPS in Q2 FY27?
Basic loss per share was ₹0.01, against a loss of ₹0.03 in Q2 FY26.
How did Shreyas Intermediates shares react to the Q2 FY27 results?
On the reaction day the stock moved −1.9% from the previous close; the median Commodity Chemicals stock moved +0.0%.
When did Shreyas Intermediates announce its Q2 FY27 results?
On 23 October 2026, in a filing to the BSE.
Sources
- Board Meeting Intimation for Meeting To Be Held On 23.10.2026 At The Registered Office Of The Company At 04:00 P.M. In Terms Of Regulation 29 Of SEBI (LODR) Regulations, 2015. (BSE, 15 October 2026) · PDF
- Board Meeting Outcome for Board Meeting Outcome For Outcome Of Board Meeting For Meeting Held On 23.10.2026 (BSE, 23 October 2026) · PDF
- Standalone Unaudited Financial Result For Quarter And Half Year Ended 30.09.2026 (BSE, 23 October 2026) · PDF
How this was written: every figure in the tables and charts is calculated from the company’s filed results (XBRL) and MarketPing’s price measurements. The text is drafted with AI from those figures and the filings, and a checker removes any sentence carrying a number it cannot trace to them. How we write these.
This is information, not investment advice. MarketPing does not recommend buying or selling any security.